REDEFINE-1

Clinical trial of CagriSema in obesity, showing weight loss of -22.7% at 68 weeks compared with -2.3% on placebo. Published in NEJM in 2025.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.